Predicting Abrocitinib Efficacy at Week 12 Based on Clinical Response at Week 4: A Post Hoc Analysis of Four Randomized Studies in Moderate-to-Severe Atopic Dermatitis
基于第 4 周的临床反应预测阿布昔替尼在第 12 周的疗效:一项针对中重度特应性皮炎的四项随机研究的事后分析
期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-024-01183-3
Armstrong, April W; Alexis, Andrew F; Blauvelt, Andrew; Silverberg, Jonathan I; Feeney, Claire; Levenberg, Mark; Chan, Gary; Zhang, Fan; Fostvedt, Luke